At the AACR Annual Meeting 2026, a session highlighted progress from four Cancer Grand Challenges teams on the interplay...
In the final days of 2019, the U.S. Food and Drug Administration (FDA) expanded the use of a previously...
In 2019, research continued to drive progress across the spectrum of cancer care in the form of new and...
In November and the first half of December, the U.S. Food and Drug Administration (FDA) announced three approvals for...
As the year winds down, here’s our final edition of Editors’ Picks for 2019. This regular feature highlights one...
Immunotherapeutic advances have dramatically changed the treatment landscape for a host of different cancer types. Notably, immune checkpoint inhibitors...
Editor’s note: When the San Antonio Breast Cancer Symposium (SABCS) kicks off next week, researchers will present the results...
As 2019 draws to a close, the American Association for Cancer Research (AACR) is grateful for our growing ranks...
Each month, the editors from the portfolio of scientific journals published by the American Association for Cancer Research (AACR)...
Earlier this month, the U.S. Food and Drug Administration (FDA) announced that the Office of Hematology and Oncology Products...
November is National Family Caregivers Month—a time to raise awareness for the approximately 3 million people in the U.S....